Medicine by Sfakianakis Alexandros

ClinicalTrials

A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors

Conditions:   Malignancy;   Non-hodgkin Lymphoma;   Multiple Myeloma;   Breast Cancer;   Ovarian Cancer;   Soft Tissue Sarcoma;   Squamous Cell Carcinoma;   Head and Neck Cancer;   DLBCL;   Mantle Cell Lymphoma;   Follicular Lymphoma;   Leiomyosarcoma;   Pancreatic Cancer;   Sarcoma;   CLLIntervention:   Drug: CYT-0851Sponsor:   Cyteir Therapeutics, Inc.Not yet recruiting

ClinicalTrials

1d

Comparing Normal Radiation Treatment Areas to Reduced Treatment Areas in Head and Neck Cancer

Condition:   Head and Neck CancerInterventions:   Radiation: Radiotherapy to all dissected areas;   Radiation: Omit radiation to pN0 neckSponsor:   Lawson Health Research InstituteNot yet recruiting

ClinicalTrials

1d